Shuwei Ren
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CYP4B1 inhibits lung adenocarcinoma metastasis by downregulating slug transcription via Sp1.
Journal: Clinical & experimental metastasis
Published: January 06, 2026
Pan-cancer analysis combined with experimental validation revealed that KTN1 is an immunological and prognostic biomarker.
Journal: Translational cancer research
Published: May 06, 2024
TP53-specific mutations serve as a potential biomarker for homologous recombination deficiency in breast cancer: a clinical next-generation sequencing study.
Journal: Precision clinical medicine
Published: January 08, 2024
FAT1 as a tumor mutation burden specific gene affects the immunotherapy effect in head and neck squamous cell cancer.
Journal: Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
Published: December 10, 2023
Jun-APOE-LRP1 axis promotes tumor metastasis in colorectal cancer.
Journal: Biomolecules & biomedicine
Published: May 05, 2023
Abnormal genetic and epigenetic patterns of m6A regulators associated with tumor microenvironment in colorectal cancer.
Journal: Translational cancer research
Published: February 09, 2023
A Pan-Cancer Analysis of the Oncogenic Role of Nuclear Transport Factor 2 in Human Cancers.
Journal: Frontiers in oncology
Published: December 05, 2021
Lnc00892 competes with c-Jun to block NCL transcription, reducing the stability of RhoA/RhoC mRNA and impairing bladder cancer invasion.
Journal: Oncogene
Published: May 09, 2021
miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: October 03, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026